Notice names this product. Macleods Pharmaceuticals’s Olanzapine Tablets is named in FDA Class III recall D-0867-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification. Identifying details: Lot: BOB22321A, Exp 07-31-2027.. Units affected: 22,032 30-count bottles. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
Company / brand: Macleods Pharmaceuticals recalls
Affected product: Olanzapine Tablets recall status
Official ID D-0867-2026 · Official record ↗
See all Macleods Pharmaceuticals recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 12:00 PM UTC.